A meta-analysis of 89 such studies reporting CSF p-tau concentrations using single or multiple phosphorylation sites identified an AD to control ratio of 1.88 (AD n = 7498; control n = 5126) [104], with all 89 studies reporting a ratio greater than one. Here, MAPT is linked to Alzheimer disease.